GCG and inflammatory bowel disease: Mucosal GLP2 concentrations are reduced in areas of colonic inflammation in mice with inflammatory bowel disease [12], and treatment with GLP2 or GLP2-2G has been shown to reduce inflammation and severity of disease in a variety of relevant models.